Immune-mediated Thrombotic Thrombocytopenic Purpura

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-05-29
Clinical Trial Update: A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) [Phase 2]
A Phase 2 pilot study of efgartigimod for immune-mediated thrombotic thrombocytopenic purpura (iTTP) is currently recruiting.